Press releases

Press release
New data from the phase I study of birinapant in combination with Keytruda® will be presented at the ASCO 2019

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today informs that new data from the phase I study of birinapant in...

Read more
Press release
Positive data from the remetinostat phase II study in basal cell carcinoma presented at SID Annual meeting

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that positive data from the investigator-initiated study evaluating the effects of...

Read more
Press release
Resolutions at the Annual General Meeting in Medivir on 9 May 2019

Approval of profit and loss accounts and balance sheets, and discharge from liability of the board members and the managing directorThe...

Read more
Press release
Data from the remetinostat phase II study in basal cell carcinoma patients to be presented at the 2019 SID Annual meeting

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that data from the investigator-initiated study evaluating the effects of remetinostat...

Read more
Press release
Safety and efficacy data from the MIV-711 phase II open label extension study presented at the OARSI world congress

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today informs that new data from the phase II program of MIV-711, has...

Read more
Press release
MEDIVIR AB – INTERIM REPORT, JANUARY – MARCH 2019

Clinical studies progress according to plan January – MarchSignificant events during the quarter The phase II study of birinapant in combination...

Read more
Press release
Data from the MIV-711 phase II program to be presented at the OARSI world congress

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today informs that new data from the phase II program of MIV-711, will...

Read more
Press release
Medivir appoints new CFO

Stockholm, Sweden – Medivir AB (Nasdaq Stockholm: MVIR) today announces the appointment of Magnus Christensen as new CFO of Medivir effective...

Read more
Press release
Notice of Annual General Meeting of Medivir AB (publ)

The shareholders of Medivir AB (publ) are hereby summoned to the annual general meeting on Thursday 9 May 2019 at 2...

Read more
Press release
Medivir’s Annual Report for 2018 is published

Stockholm, Sweden - Medivir AB (Nasdaq Stockholm: MVIR) today announces that the Annual Report for 2018 now is available at the...

Read more
Press release
The Nomination Committee´s proposal for new Board of Directors to the Annual General Meeting 2019

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces the Nomination Committee’s proposal for a new Board of Directors to...

Read more
Press release
Medivir to present at the Stockholm Corporate Finance Life Science Seminar on March 13

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announces that the company will participate at the Stockholm Corporate Finance 11th Life...

Read more